PorTal Access Announces FDA Clearance of FLEXI-PORT™ family of implantable vascular access ports

PorTal Access, Inc., an innovative medical device company advancing vascular access technologies, today announced that the ...
ascopubs.org

Totally Implantable Venous Access Ports Systems for Patients Receiving Chemotherapy for Solid Tissue Malignancies: A Randomized Controlled Clinical Trial Examining the Safety ...

Heterozygous Germline ATM Mutations Do Not Contribute to Radiation-Associated Malignancies After Hodgkin's Disease PURPOSE: To examine the safety, efficacy, costs, and impact on quality of life of ...
ascopubs.org

Totally implantable venous access port: A prospective long-term study of early and late complications in adult patients with cancer.

Radiation-induced CD4 and CD8 Τ-lymphocyte apoptosis analysis in patients with prostate adenocarcinoma overexposed to radiations (EPOPA).
The Florida Times-Union

Mekon Safety Huber Needle: Built for Safer Port Access and Confident Clinical Handling

SHANGHAI, SHANGHAI, CHINA, June 11, 2026 /EINPresswire.com/ — As long-term vascular access therapies continue to expand across oncology, infusion treatment, and ...